MondayDec 20, 2021 2:17 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Standing Distinct in Advancing Psychedelic Medicine

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) recently released financials and a business update for the third quarter ending Sept. 30, 2021. During this reporting period, the company filed three patent applications; successfully synthesized a novel psilocin analogue with improved pharmaceutical properties; launched Mindleap 2.0, an updated version of its proprietary virtual health platform; and completed its spin-out transaction of ALT House Cannabis Inc. “The highlight of this quarter was the five-year research agreement Mydecine Innovations entered with Johns Hopkins University School of Medicine… The agreement gives the company’s medical and scientific research teams the resources needed to explore things…

Continue Reading

MondayDec 20, 2021 1:57 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Advancing Core Research, Commercial Production Programs, Identifying Pipeline Expansion Opportunities

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, recently provided an update sharing significant milestones reached in 2021 for both of its operating arms, MINDCURE Research and MINDCURE Technology. MINDCURE Research offered several updates, including important milestones in its synthetic ibogaine manufacturing; the company is currently on schedule to provide Good Laboratory Practice (“GLP”) ibogaine to its research partners by the second quarter of 2022. In addition, a pre-clinical update from MINDCURE confirms that it intends to send ibogaine material to its pre-clinical research partner. Initially, the product will be…

Continue Reading

MondayDec 20, 2021 1:27 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Working to Make Fan Pass a Household Name

Friendable’s (OTC: FDBL) Fan Pass platform has seen massive growth since its launch in July 2020, with thousands of established and independent artists signing up in the last 12 months. The platform has reached multiple significant milestones this year, including the launch of an updated version, the publication of new mobile applications in both the Apple Store and Google Play, and the release of an Artist Pro offering that brings new features and benefits for members. A recent article reads, “The company goes into 2022 with a commitment to continue expanding its reach and offering to artists and fans alike.…

Continue Reading

MondayDec 20, 2021 12:54 pm

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Leveraging The Bitcoin Lightning Network’s Growing Popularity to Expand Dedicated PaaS Offering

The Bitcoin Lighting Network, for efficient bitcoin transactions, is seeing more players who are interested in providing an offering that is low fee and instantaneous It is estimated that 700 million users will be utilizing the Lightning Network by 2030 LQwD’s proprietary platform-as-a-service offering is designed to simplify users’ access to the Lightning Network and make it far easier to complete faster, more affordable transactions While LQwD remains the only public company focused on Bitcoin Lightning Network, a growing number of companies and entities are becoming interested in leveraging the network’s opportunities The Lightning Network is becoming a popular way…

Continue Reading

MondayDec 20, 2021 12:33 pm

Mining Developer StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Builds Gold & Silver Assets as Analysts Eye Inflation Trends

Mineral property exploration company StraightUp Resources is building a portfolio of gold and silver mining options in Canada, the United States and Peru The company has been particularly focused thus far on its options in Ontario, Canada’s prolific Red Lake mining district, where airborne surveys and follow up ground investigation have been completed to analyze site potential While gold’s market performance has been lackluster in recent months due to investor skittishness, many analysts predict that inflationary pressures will create a resurgence of gold-hungry activity Silver-bullish investors are likewise predicting the metals’ prospects will improve in coming years as a result…

Continue Reading

MondayDec 20, 2021 12:17 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Ranks in List of Top 101 Canadian F&B Startups and Companies

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has been named one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. The ranking recognizes the company’s leadership position within both the food & beverage and cannabis product categories. Companies listed in the rankings include cutting-edge startups and established brands alike, but each company is known for innovation within their sector, exceptional growth and societal impact. BevCanna was within the group of selected companies that exhibited exceptional performance. In addition, BVNNF was also included within…

Continue Reading

MondayDec 20, 2021 12:08 pm

RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects

RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions RYAH supports cancer research and treatment with IoT product ecosystem comprised of volume-control devices, medicine-carrying components, mobile applications RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, recently released a medical cannabis report on cancer and the adverse effects of cancer treatment (https://ibn.fm/Es52b). Data from…

Continue Reading

MondayDec 20, 2021 11:59 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partners with Leading Mechanical, Plant Engineering Firm

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is partnering with Dürr, one of the world's leading mechanical and plant engineering firms. Durr brings extensive expertise in automation and digitalization to the partnership, which is designed to focus on MULN’s EV manufacturing footprint. According to the agreement, Dürr, which has extensive expertise in automation and digitalization, will support Mullen’s Advanced Manufacturing and Engineering Center (“AMEC”) with full integration for vehicle assembly and complete paint shop technologies; the engineering center is located in Tunica, Mississippi. "Dürr is a leading international manufacturing systems and technology provider for the automotive industry,”…

Continue Reading

MondayDec 20, 2021 11:49 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), an Undervalued Opportunity for Investment

Mydecine’s and CMPS’ stocks have been grossly undervalued largely due to a lack of understanding of the psychedelic space  The situation presents a unique opportunity for investment, as Roth Capital Partners issued a $3 buy rating for 2022 Mydecine has put systems and infrastructure in place to bank on the growing PTSD treatment, smoking cessation, and the health and wellness apps market, in its drive to increase value for its shareholders There has been a huge misunderstanding of the psychedelic space and the potential that this industry has, specifically regarding the treatment of Post-Traumatic Stress Disorder (“PTSD”) and smoking cessation.…

Continue Reading

MondayDec 20, 2021 11:39 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces General Meeting Voting, Publication of Key Article on CBN as Possible Glaucoma Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, held its general meeting on Dec. 17, 2021, and approved the election of all director nominees. Those elected will hold office until the next annual shareholder meeting or until their successors are elected or appointed. The company also noted that all of the matters outlined for consideration and approval in InMed’s notice of meeting and management information circular were approved. In addition, the company announced that an article discussing cannabinol (“CBN”) as a potential treatment option for glaucoma has been published in a peer-reviewed journal.…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered